Mesoblast gets boost from positive FDA news in USA

MELBOURNE: Shares in Australian biopharmaceutical company Mesoblast jumped as much as 25 per ... read more
Aspen’s Eureka takeover hits hurdle as developer lifts stake

PERTH: The battle for listed affordable accommodation provider Eureka is expected to intensify ... read more